Medicare Enrolled
Carrie Defuss
Nurse Practitioner - Family · Joliet, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Defuss from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Defuss?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Defuss
Carrie Defuss is a nurse practitioner - family in Joliet, IL, with 8 years of NPI registration. Based on federal Medicare data, Defuss performed 65,686 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Defuss received a total of $8,067 from 39 pharmaceutical and/or device companies across 259 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Defuss is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years of NPI registration
▲ Top 0% volume in IL
$8,067 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗65,686
Medicare services
Top 0% in IL for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
58,400 | $0 | $0 |
| Injection, degarelix, 1 mg | 3,040 | $3 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
737 | $56 | $140 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
554 | $2 | $17 |
| Leuprolide injectable, camcevi, 1 mg | 504 | $62 | $130 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
476 | $8 | $85 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
270 | $9 | $65 |
| Electrical stimulation therapy, per 15 minutes Application of electrical stimulation to the body with a therapist present. The service is billed for each 15-minute increment of treatment. |
136 | $8 | $60 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
121 | $8 | $44 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
118 | $40 | $275 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 114 | $134 | $1,395 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
87 | $8 | $19 |
| Fitting and insertion of vaginal support device A procedure to measure, fit, and insert a device designed to support vaginal structures. |
87 | $47 | $190 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
85 | $43 | $637 |
| Non-rubber pessary A non-rubber device inserted into the vagina to support pelvic organs. |
85 | $50 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $84 | $202 |
| Antimicrobial drug evaluation Assessment of the patient's response to antibiotic, antifungal, or antiviral therapy. |
79 | $7 | $28 |
| Physical therapy exercise, per 15 min A therapy session using exercises to improve strength, endurance, range of motion, and flexibility. Each 15-minute unit is billed separately. |
79 | $15 | $90 |
| Functional capacity test, per 15 minutes A test or measurement to assess functional capacity. The service is billed for each 15-minute increment. |
79 | $24 | $115 |
| Rectal sensitivity and function study A test to evaluate the sensitivity and functional performance of the rectum. |
76 | $192 | $908 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
76 | $23 | $163 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $33 | $116 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
69 | $8 | $37 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
54 | $59 | $412 |
| PSA test (prostate cancer screening) | 34 | $18 | $77 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
32 | $25 | $73 |
| Electronic analysis of implanted neurostimulator This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation. |
29 | $34 | $191 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
22 | $8 | $16 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $84 | $252 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
19 | $54 | $367 |
| Catheter specimen collection A procedure to collect a specimen using a catheter. This service is available in all places of service. |
16 | $8 | $23 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $126 | $359 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $50 | $132 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,067
Total received (2021-2024)
Avg $2,017/year across 4 years
Top 2% in IL for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
259
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,564
2023
$1,740
2022
$1,272
2021
$491
Payments by company (2024)
Axonics, Inc.
$1,896
Medtronic, Inc.
$919
Sumitomo Pharma America, Inc.
$301
Olympus America Inc.
$259
Teleflex LLC
$195
Endo USA, Inc.
$158
AstraZeneca Pharmaceuticals LP
$119
Tempus AI, Inc
$112
Laborie Medical Technologies Corp.
$111
Bayer Healthcare Pharmaceuticals Inc.
$68
Tolmar, Inc.
$59
180 Medical, Inc.
$58
VERTEX PHARMACEUTICALS INCORPORATED
$45
ConvaTec Inc.
$45
COLOPLAST CORP
$43
Janssen Biotech, Inc.
$40
Myriad Genetic Laboratories, Inc.
$37
Astellas Pharma US Inc
$30
Dendreon Pharmaceuticals LLC
$30
Antares Pharma, Inc.
$25
DENTSPLY IH AB
$15
Top 3 companies account for 68.3% of 2024 payments
All-time payments by company (2021-2024) ›
Axonics, Inc.
$2,111
Medtronic, Inc.
$919
Sumitomo Pharma America, Inc.
$707
AstraZeneca Pharmaceuticals LP
$568
Olympus America Inc.
$378
Teleflex LLC
$336
Janssen Biotech, Inc.
$325
UROVANT SCIENCES INC
$253
Astellas Pharma US Inc
$191
ConvaTec Inc.
$187
Bayer HealthCare Pharmaceuticals Inc.
$175
Endo USA, Inc.
$158
180 Medical, Inc.
$151
Bayer Healthcare Pharmaceuticals Inc.
$146
ABBVIE INC.
$131
Tempus AI, Inc
$112
Laborie Medical Technologies Corp.
$111
TOLMAR Pharmaceuticals, Inc.
$108
Tolmar, Inc.
$98
Antares Pharma, Inc.
$90
Endo Pharmaceuticals Inc.
$90
Dendreon Pharmaceuticals LLC
$81
Palette Life Sciences, Inc.
$73
GENZYME CORPORATION
$63
Alnylam Pharmaceuticals Inc.
$62
Myriad Genetic Laboratories, Inc.
$59
Blue Earth Diagnostics Limited
$48
Merck Sharp & Dohme LLC
$46
VERTEX PHARMACEUTICALS INCORPORATED
$45
COLOPLAST CORP
$43
UroGen Pharma, Inc.
$36
Supernus Pharmaceuticals, Inc.
$32
Amgen Inc.
$29
Hollister Incorporated
$21
Progenics Pharmaceuticals, Inc.
$20
Rochester Medical Corporation
$20
AbbVie Inc.
$17
DENTSPLY IH AB
$15
CARDINAL HEALTH 414 LLC
$13
Top 3 companies account for 46.3% of all-time payments
Associated products mentioned in payments ›
AVEED · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · CYSTO-NEPHRO VIDEOSCOPE · EDEX · ELIGARD · ERLEADA · GEMTESA · GENTLECATH · GENTLECATH GLIDE · GIVLAARI · GentleCath · Goby · INTERSTIM · JATENZO · JEVTANA · KEYTRUDA · LOFRIC · LUPRON DEPOT · LYNPARZA · MYRBETRIQ · NOCDURNA · Nubeqa · ORGOVYX · OXLUMO · PROLARIS · PROVENGE · PYLARIFY · Prolia · SELF-CATH · SOLTIVE · Soltive · SpeediCath · TLANDO · UROLIFT · VaPro Plus Pocket · XIAFLEX · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family nurse practitioners in nearby ZIP areas
1,095
County median income
$107,799
Nearest hospital to ZIP centroid (approximate)
SAINT JOSEPH MEDICAL CENTER
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Defuss is a mixed practice specialist, with above-average Medicare volume (top 0% in IL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Defuss experienced with testosterone injection?
Based on Medicare claims data, Defuss performed 58,400 testosterone injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Defuss receive payments from pharmaceutical companies?
Yes. Defuss received a total of $8,067 from 39 companies across 259 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Defuss's costs compare to other family nurse practitioners in Joliet?
Defuss's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Defuss) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Joliet
Browse family nurse practitioners in Joliet ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in IL
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in IL
Which IL family nurse practitioners receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology